Published January 12, 2018
Regenerative medicine is a branch involved in the repair, replace and regenerate tissues and organs affected due to injury, disease or natural aging process. These medicines are having the ability to restore the functionality of cells and tissues and are used in various strategies like cell therapy, gene therapy, and tissue engineering. Many firms and industries are trying to develop and improve the technological approaches to increase the market.
Americas Regenerative Medicines Market Segments size & growth:
The market is valued at USD 17.625 Billion in 2017 and is expected to reach USD 51.453 Billion by 2024 at a CAGR of 23.8%. The major factors influencing the market growth are growing prevalence of chronic diseases such as bone and joint diseases and trauma emergencies, growing need for orthopedic surgeries, innovation in stem cell therapy, technological innovations and tissue engineering.
Americas Regenerative Medicines Market Segments share:
On the basis of application, the market is segmented into orthopedic, oncology, diabetes, cardiology and central nervous system. Among this oncology is having the largest share and fastest growth in the market. The market is majorly divided into products, application, therapy, material and agent type. On the basis of products, it is segmented into cell-based and acellular and on the basis of therapy, the market is segmented into the cell, therapy, tissue and gene therapy. The application is segmented into orthopedic, dermatology, cardiology, oncology and central nervous system. On the basis of material, the market is categorized into algae-derived alginate, synthetic polymer, polylactide- coglycolide, polyethylene glycol and hydrogels. Final segmentation is based on agent type it is into biologics, cell-based medical devices, and biopharmaceuticals. On the basis of geography, the market is predominant in Asia-Pacific and it continues during the forecast period. North America is in its growing phase and is holding the largest in regenerative medicines market as the therapies are in the 3rd phase of clinical trials.
Americas Regenerative Medicines Market Trends:
Americas Regenerative Medicines Market Research Report Includes:
1.1. Executive Summary
1.2. Market Definition
1.3. Scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.4. SWOT Analysis
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1.1 Increase in corporate partnerships to accelerate development and commercialize of regenerative medicine.
4.1.2 Increase in global healthcare expenditure.
4.1.3 Rapid growth in aging population.
4.1.4. Prevalence of chronic diseases and genetic disorders.
4.2.1 Cost of treatment.
4.2.2 Complex regeneration process.
4.2.3. Lack of guidelines.
4.2.4. Ethical concerns with the use of embryonic stem cell for research and development.
4.3.1. Strong product pipeline.
4.3.2. The great demand for organ transplantation.
4.4.1 Stringent regulatory policies pertaining to stem cell technologies.
5. Americas Regenerative Medicine Market – By Product
5.2 Cell-based products
5.2.1 Allogeneic products
5.2.2 Autologous products
5.3 Acellular products
6. Americas Regenerative Medicine Market – By Application
6.2 Orthopaedic and musculoskeletal disorders
6.5 Central nervous system diseases
6.8 Bone graft substitutes
7. Americas Regenerative Medicine Market – By Therapy
7.2 Cell therapy
7.4 Tissue therapy
7.5 Gene therapy
8. Americas Regenerative Medicine Market – By Material
8.2 Algae derived alginate
8.3 Synthetic polymer
8.5 Poly-ethylene glycol
9. Americas Regenerative Medicine Market – by Agent type
9.2.1 Autologous fibroblasts
9.2.2 Hematopoietic stem and progenitor cells
9.3 Cell based medical devices
9.3.1 Allogenic fibroblasts
9.3.2 Cell extraction
9.4 Bio pharmaceuticals
9.4.1 Tricalcium phosphate
9.4.2 Osteogenic protein
10. Americas Regenerative Medicine Market – By geography
11. Americas Regenerative Medicine Market – Company Profiles
11.1 Celgene Corporation
11.2 Vertex pharmaceuticals
11.3 Acelity L.P. Inc
11.4 Stem cells, Inc.
11.5 Organogenesis Inc
11.6 Nuvasive Inc
11.7 Mesoblast Ltd
11.8 Advantagene Inc
11.9 Vertical corporation
11.10 Cytori therapeutics
12. Americas Regenerative Medicine Market – Competitive Landscape
12.1 Market Share Analysis
12.2 Strategies Adopted by top companies
12.3 Merges, Acquisitions, Collaborations & Agreements
13. Market Insights
13.1 Industry Experts Insights
13.2 Analysts Opinions
13.3 Investment Opportunities
14.1 List of tables
14.2 List of figures